Your session is about to expire
← Back to Search
Methylene Blue Photodynamic Therapy for Abscess
Study Summary
This trial is testing a new way to treat deep tissue abscesses using light therapy along with a medicine called methylene blue. The goal is to see if this is a safe and effective treatment.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently taking medication for mental health that affects serotonin.You have a very weak heart and lungs, or your blood pressure is unstable.You have dead tissue that needs to be surgically removed.You have large abscesses (pockets of infection) that are too big to be drained safely using a needle and imaging guidance.If the patient is a woman, she must have a negative pregnancy test.The size of the abscess cannot be larger than 8 cm, but it can be complicated or difficult to treat.You are allergic to contrast media, narcotics, sedatives, atropine, or eggs.
- Group 1: MB-PDT, 15 min illumination
- Group 2: MB-PDT, 20 min illumination
- Group 3: MB-PDT, 25 min illumination
- Group 4: MB-PDT, 30 min illumination
- Group 5: MB-PDT, 5 min illumination
- Group 6: MB-PDT, 10 min illumination
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the results of previous experiments involving MB-PDT with a thirty minute light exposure?
"Currently, 22 MB-PDT, 30 min illumination trials are ongoing with 3 of them being in the final stage. Moreover, 36 different clinical sites across the United States have opened their doors to participating patients for this specific trial. Among these locations is New Haven Connecticut."
What is the scope of patient recruitment for this research?
"Verbally affirmed, this clinical trial is open for recruitment as per the information on clinicaltrials.gov. It was first introduced on September 1st 2014 and most recently amended on March 23rd 2022. The research initiative requires 21 participants from one centre of study."
How is MB-PDT, 30 min illumination typically implemented for treatment?
"MB-PDT with a 30 minute illumination time is commonly used to address urethritis, however it has also found success in combatting issues such as nephritis, parenteral nutrition, total and inflammation."
Has the U.S. Food and Drug Administration sanctioned thirty minutes of MB-PDT for therapeutic use?
"Although there is some evidence suggesting efficacy, the limited amount of data surrounding MB-PDT safety gives it a rating of 1 on our scale."
Is there still an opportunity to join this research endeavor?
"According to records hosted on clinicaltrials.gov, enrollment for this medical research is ongoing. The trial was initiated on September 1st 2014 and last modified on March 23rd 2022."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger